secwatch.observer — SEC 8-K summary
======================================

Issuer:     CTS CORP (CTS)
CIK:        0000026058
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001193125-25-268239
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CTS appoints Kimberly Banks MacKay to board, effective Nov 5, 2025
------------------------------------------------------------------

- Board expands from 7 to 8 members; MacKay fills newly created vacancy.
- MacKay is SVP, General Counsel & Corporate Secretary of West Pharmaceutical Services.
- She will serve on Nominating, Governance & Sustainability and Technology & Transactions committees.
- Compensation is consistent with other non-employee directors, per prior proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/26058/000119312525268239/0001193125-25-268239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/26058/000119312525268239/cts-20251105.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-268239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer